Evidence map›Paper›PMID 35596895›Full record

ArticleJournal of materials science. Materials in medicine2022

Bone response in vivo of Ti-45Zr alloy as dental implant material.

Pinghua Ou, Taomei Zhang, Jianying Wang, Cui Li, Chunsheng Shao, Jianming Ruan

Abstract read
In one paragraph

Article in Journal of materials science. Materials in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Silk Fibroin/ZnO Coated TiOMaterials (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pinghua OuDepartment of Stomatology, The Third Xiangya Hospital, Central South University, 410013, Changsha, Hunan, PR China.
Taomei ZhangState Key Laboratory of Powder Metallurgy, Central South University, 410083, Changsha, Hunan, PR China.
Jianying WangState Key Laboratory of Powder Metallurgy, Central South University, 410083, Changsha, Hunan, PR China.
Cui LiDepartment of Stomatology, The Third Xiangya Hospital, Central South University, 410013, Changsha, Hunan, PR China.
Chunsheng ShaoDepartment of Stomatology, The Third Xiangya Hospital, Central South University, 410013, Changsha, Hunan, PR China.
Jianming RuanState Key Laboratory of Powder Metallurgy, Central South University, 410083, Changsha, Hunan, PR China. jianming@csu.edu.cn.ORCID http://orcid.org/0000-0002-0472-7982

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ti-Zr alloys have gained increasing attention as a new metallic biomaterial, being used as implants for both orthopedics and dentistry. More recently, our group found promising results for the Ti-45Zr alloy, which presented a low elastic modulus, a pronounced and excellent mechanic character, and excellent cell compatibility in vitro. However, its biocompatibility and potential to promote osteogenesis in vivo remained unclear. In the present study, the biocompatibility, osteointegration ability, and immune response effects of the Ti-45Zr alloy were evaluated in animal experiments. The results showed that the alloy had good blood compatibility and no body side effects. After implantation in vivo, the inflammation turned out well and was beneficial to the polarization of macrophages. Additionally, the Ti-45Zr alloy presented a good osteointegration ability. Overall, these results confirmed that the Ti-45Zr alloy can be used as a dental implant material.

Indexed as

Dental ImplantsAlloysAnimalsBiocompatible MaterialsDental MaterialsElastic ModulusMaterials TestingTitaniumAlloysBiocompatible MaterialsDental ImplantsDental MaterialsTitanium

Identifiers

PMID35596895
PMCPMC9124165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.